Gm581 Activators
Gfy Activators are a class of chemical compounds characterized by their ability to modulate the activity of Gfy proteins. These activators typically function by binding to the Gfy proteins, thereby triggering a conformational change that can enhance the protein's natural activity. The mechanism of action for Gfy Activators tends to involve direct interaction with the protein's active site or allosteric sites, which are distinct from the active site but still influence the protein's function when occupied by an effector molecule. This interaction can lead to an increase in the protein's affinity for its substrates or interactants, or it may stabilize the protein in a particular conformation that is associated with a higher activity state.
The molecular diversity within the Gfy Activator class is considerable, as these compounds can vary widely in their structure and physicochemical properties. Some may be small, organic molecules with a relatively simple structure, while others might be more complex, perhaps incorporating multiple rings or functional groups that enable them to engage in more specific interactions with their target proteins. The design of these activators often takes advantage of the unique structural features of the Gfy proteins, including grooves, pockets, or surface residues that are amenable to small molecule binding.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC activation can lead to phosphorylation of proteins that are part of the Golgi apparatus signaling pathways. As GOASR is associated with olfactory signaling regulation, PKC-mediated phosphorylation events could facilitate GOASR's role in signal transduction processes within the Golgi. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a non-specific inhibitor of phosphodiesterases, which leads to an increase in cAMP by preventing its degradation. Elevated cAMP levels can result in the activation of PKA and subsequent phosphorylation within the Golgi apparatus, indirectly enhancing the functional activity of GOASR. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A, preventing the dephosphorylation of proteins. Persistent phosphorylation can augment processes within the Golgi, potentially enhancing the role of GOASR in olfactory signaling regulation through prolonged activation states of Golgi-associated proteins. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine engages adrenergic receptors, which can increase intracellular cAMP levels via G protein-coupled receptor signaling. The rise in cAMP may activate PKA, which in turn could phosphorylate proteins within the Golgi apparatus, thereby enhancing GOASR's functional activity as it participates in signaling regulation. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A is a fungal metabolite that disrupts the structure and function of the Golgi apparatus. By inhibiting protein transport from the ER to the Golgi, it can cause a build-up of signaling molecules within the Golgi, which may indirectly increase the functional activity of GOASR through enhanced local concentration of signaling partners. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
6-Bnz-cAMP is a cAMP analog that activates PKA. By mimicking cAMP, it can stimulate PKA activity, resulting in phosphorylation events within the Golgi apparatus. This can enhance the functional activity of GOASR by promoting its role in signaling processes tied to the Golgi's function. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase-3 (GSK-3). Inhibition of GSK-3 can lead to changes in phosphorylation states of proteins associated with the Golgi apparatus, potentially enhancing the functional activity of GOASR through modulation of protein interactions and signaling cascades within the Golgi. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases, leading to increased phosphorylation within cells. As with okadaic acid, sustained phosphorylation can influence Golgi apparatus function and signaling, which may enhance the role of GOASR in regulating Golgi-associated signaling pathways. | ||||||